GSK2636771 is a potent, orally bioavailable, PI3K beta-selective inhibitor, currently in Phase I/II trials.

June 21, 2017

prudect name : GSK2636771 is a potent, orally bioavailable, PI3K beta-selective inhibitor, currently in Phase I/II trials.
GSK2636771

Synonyms: CAS NO: 1372540-25-4Molecular Formula: C₂₂H₂₂F₃N₃O₃Molecular Weight: 433.42Purity: 98% minSolubility: In DMSOStorage: -20°C

SU5402 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18515482